Influenza Other Respi Viruses. 2019;13:535-546. | 535 wileyonlinelibrary.com/journal/irv 1 | INTRODUC TI ON Animal models have proved critical in developing concepts of immunity to infection. Non-human primates (NHP) are a highly humanrelevant disease model for infectious agents due to high genetic conservation between humans and NHP. 1-3 However, significant cost and ethical issues often necessitate the use of smaller animal models for both basic and translational research. Mice (Mus musculus) are a favoured small animal model due to widespread availability, incisive transgenic models, comprehensive genomic information 4 and readily available reagents. However, for many viruses, alternative animal models better recapitulate human physiology and disease. Ferrets (Mustela putorius furo) have been employed to study the pathogenesis of a variety of human pathogens, including human and avian influenzas, coronaviruses including severe acute respiratory syndrome (SARS-CoV), 5-14 human respiratory syncytial virus (HRSV), 15-20 human metapneumovirus (HMPV), 21 Ebola virus 22-28 and henipavirus (Nipah virus and Hendra virus). 29-34 While ferrets
| FERRE TS A S AN INFLUENZ A PATHOG ENE S IS AND TR ANS MISS ION MODEL
Ferrets can be directly infected with influenza from human clinical isolates without prior adaptation. Influenza infection of ferrets recapitulates key hallmarks of human clinical disease, such as high fever accompanied by sweating, as well as respiratory symptoms such as rhinorrhea and sternutation. 35 , 36 The shared susceptibility to influenza infection is based on similarity in respiratory tract physiology, where a predominance of α2,6-linked sialic acid (SA) receptors in the upper respiratory tract of ferrets mimics that of humans, [37] [38] [39] [40] [41] unlike α2,3-SA prevalent in other species such as mice. Ferrets are an extremely valuable model for studies on influenza pathogenesis 42, 43 and both direct and aerosol transmission. 44, 45 Critically, ferrets are a susceptible host for highly pathogenic avian strains of influenza with pandemic potential, such as H5N1 and H7N9, although disease severity in infected ferrets is somewhat variable. 42, [46] [47] [48] Similar variability in pathogenesis has been reported for some seasonal strains such as recent H3N2 isolates, 49, 50 which display a range of disease severity in humans 51 but generally remain mild in ferrets. 52, 53 
| FERRE TS FOR INFLUENZ A SURVEILL AN CE AND VACCINE DE VELOPMENT
Ferrets play a critical role in annual seasonal influenza vaccine strain selection. Antigenic drift in circulating strains is monitored primarily using hemagglutination inhibition (HI) assays on serum from ferrets infected with recently circulating human viral isolates. 54, 55 In both ferrets and humans, HI titres are a marker of protection from acquiring infection and currently the key immunological correlate for assessing potential vaccine effectiveness.
Currently licensed seasonal vaccines, historically trivalent (TIV) but increasingly quadrivalent inactivated vaccines (QIV), can protect both ferrets 56, 57 and humans 58, 59 from infection and disease.
Protection is mediated through neutralising antibodies targeting a cluster of epitopes surrounding the viral receptor-binding domain (RBD) within the highly variable hemagglutinin (HA) head domain (HA1). 60, 61 Inactivated influenza vaccines significantly reduce mortality rates in children 62, 63 and severe disease in adults. 58, 64 However, vaccine protection is notoriously strain-specific, and mismatches between vaccine and circulating strains through antigenic drift lead to low vaccine efficacy. [65] [66] [67] There are global efforts to increase the breadth of protection of influenza vaccines, with an eventual goal of universal protection (reviewed in 68 ) , and most strategies have been evaluated in ferret models. A non-exhaustive list of strategies to induce heterosubtypic immunity against influenza evaluated in ferrets include: HA stem vaccination [69] [70] [71] ; prime-boost with chimeric HA-based vaccines 72 ; use of conserved influenza proteins such as nucleoprotein (NP), [73] [74] [75] matrix-1 (M1), 74,76 matrix-2 (M2) 75, 77 and RNA polymerase subunit B1 (PB1) 74 ; replication-deficient viruses [78] [79] [80] [81] ; live attenuated formulations [82] [83] [84] ; the use of potent adjuvants such as Protollin, 85 glucopyranosyl lipid adjuvant-aqueous formulation (GLA-AF), 86 CoVaccine HT, 87 cationic adjuvant formulation 88 and poly-g-glutamic/chitosan nanogel 89 ; Escherichia coli-derived vaccines 90 ; DNA, mRNA and viral vector vaccines 75, [91] [92] [93] ; and the use of virus-like particles (VLP). 76 Additional examples of important ferret studies include (but are not limited to) evaluating the influence of changing the route of influenza inoculation on subsequent immunity 94 and the use of neuraminidase (NA) inhibitors as prophylaxis. 95 
| FERRE TS A S AN IMMUNOLOG I C AL MODEL FOR S TUDYING INFLUENZ A
The utility of ferrets for incisive immunological studies is hampered by limited reagents to study ferret immunity and a paucity of background knowledge about the ferret immune system. Some insights into ferrets' immunological responses to influenza have been gained by indirect measurements of immune gene expression such as quantitative RT-PCR (qRT-PCR), transcriptome analysis or oligonucleotide microarrays. 22, [96] [97] [98] [99] [100] For example, assessing the differential expression levels of innate and adaptive immune genes in the lungs following primary or secondary 2009 H1N1pdm infection revealed upregulation of interferon-stimulated genes involved in antiviral responses such as C-X-C motif chemokine 10 (CXCL10), 2′-5′ oligoadenylate synthase 1 (OAS1), interferon regulatory factor 1 (IRF1) and radical S-adenosyl methionine domain containing 2 (RSAD2) as well as chemokines such as CXCL16 and C-C motif chemokines 3, 4 and 5 (CCL3, CCL4 and CCL5). 98 Similarly, the degree of disease severity, virus shedding and transmission in ferrets has been associated with tumour necrosis factor (TNF) and interleukin-6 (IL-6) mRNA expression in the upper respiratory tract. 97 However, mRNA levels can correlate poorly with protein levels, 101 and techniques such as flow cytometry, bead arrays and immunohistochemistry would facilitate direct measurement of immune marker expression. To date, flow cytometric or microscopy techniques have been limited in ferrets by the lack of suitable antibodies specific for ferret immune cell markers.
Screening for cross-species reactivity has identified antibody clones recognising ferret T-cell markers such as CD3 and CD8, and an intracellular B-cell marker CD79b 102-104 (summarised in Table 1 ).
The utility of such cross-reactive reagents has been shown experimentally. For example, prime-boost immunisation using DNA and adenoviral-based influenza vaccines provided effective protection in experimentally challenged ferrets, with protection correlating to the capacity of CD3+ T cells to express interferon gamma (IFN-γ) following in vitro stimulation on peripheral blood mononuclear cells (PBMCs) with HA peptide pools. 92 Caution should be taken when using antibodies developed for other species in ferret experiments, as there may be subsets of cells displaying variable reactivity to the antibodies. 105, 106 In addition, currently available anti-ferret B-cell antibodies such as CD79α target intracellular epitopes, requiring fixation and permeabilisation. This limits downstream applications such as RT-PCR or the recovery of antigen-specific immunoglobulin sequences from sorted B cells. In the absence of cross-reactive clones, several groups have generated novel monoclonal antibodies specific for ferret cellular markers. For example, novel antiferret CD4-, CD8-and CD5-specific antibodies were derived by 109 and are reviewed in detail further below.
Using existing reagents, innate and adaptive immune responses to influenza infection 52, 108, 110 and immunisation 83, 111 have been studied and provide important insights into ferret antiviral immunity.
Following influenza challenge of naïve or vaccinated ferrets, there is a transient increase in CD11b+ expressing PBMCs at 2 d.p.i, which decreased to baseline levels by 3 d.p.i, suggesting a role for monocytes/macrophages/neutrophils or antigen-presenting cells (APC) during early infection. 110, 111 In addition, an infiltration of CD11b+ and MHC-II+ cells into lungs between 2 and 5 d.p.i was observed, which could represent lung APCs. 110 CD11b+ cells also increase in secondary lymphoid organs 10 d.p.i, 108 The influenza protein specificity of the T-cell response to influenza is beginning to be explored in ferrets using IFN-γ expression assays and other standardised protocols. 108, 114 DiPiazza et al 108 found that the majority of bulk memory CD4+ T-cell responses were specific for the M1 protein whereas non-structural protein (NS) was mainly the target for CD8+ T-cell responses, and hierarchal responses were found to change over time without preferential retention of immunodominant specificities. 115 In comparison, crossreactive ferret CD4+ T cells recognise HA and NA epitopes preferentially whereas CD8+ T cells mount immune responses towards M1, NS2 and RNA polymerase subunit A (PA), with NP as a significant antigenic target. 104 Interrogation of ferret T-cell responses with improved reagents will increase our understanding of immunodominance hierarchies analogous to studies performed in other animal models and humans (reviewed in 116 ).
Markers targeting B-cell antigens such as CD79a, CD20 and surface immunoglobulin also allow ferret B cells to be examined by immunohistochemistry and flow cytometry in ferret tissues. 108, 117, 118 B-cell frequencies are also transiently decreased 2 d.p.i 110, 111 after infection, with a corresponding increase in secondary lymphoid organs 2-5 d.p.i. 110 The number of major histocompatibility complex (MHC-II) expressing cells also increased, with no significant difference in surface immunoglobulin-positive cells by 10 d.p.i. 108 Influenza-specific ASCs were also increased by 37 d.p.i, highlighting the role of B cells in the resolution of infection. 83 Similar to T cells, B-cell HA immunodominance hierarchies have been studied widely. 122 A key target for broader antibody responses is the conserved stem domain (HA2) of HA; however, immunodominant responses against HA1 often limit antibody responses to variable regions, leading to escape from host responses. 123 Different vaccination strategies to induce broadly protective antibody responses have been studied in ferrets. 124 Using purified ferret immunoglobulins and cross-reactive polyclonal immunoglobulin antisera from mink, goat, canine and rabbits, a ferret immunoglobulin class-specific ELISA was developed. 102 The effects of prior infection on host susceptibility to re-infection, that is viral interference, have also been studied in ferrets. 126 
| FERRE TS A S AN IMMUNOLOG I C AL MODEL FOR OTHER EMERG ING VIR AL DISE A SE S
In addition to influenza, the ferret serves as a critical model for 
| SARS-CoV

SARS-CoV infection causes acute respiratory distress in humans
with mortality rates of up to 10%. 135 While worldwide outbreaks have not been reported since 2004, there is still a lack of vaccines and effective treatment measures. Ferrets display clinical signs of infection such as elevated body temperatures, sneezing, increase in lymphocyte counts and lesions in the respiratory tract and alveolar oedema 7 and are therefore a good mammalian model to study the pathogenesis of SARS-CoV (reviewed in 7, 136 ) and evaluate vaccines (reviewed in 14, [137] [138] [139] ). In terms of immunity, ferrets exhibit strong antiviral interferon responses after infection and vaccination as measured by interferon response gene expression levels. 5, 13 However, leucocyte counts and interferon-related gene expression were decreased upon re-infection, 5 suggesting that innate immune dysregulation is a possible mechanism of pathogenesis, though a protective antibody response was also evident during attempts to re-infect ferrets. 8
| Henipavirus
Emerging viruses belonging to the Paramyxoviridae family (Henipaviruses) can cause severe respiratory illness and/or encephalitis in humans. Ferrets infected with henipaviruses exhibit similar symptoms as humans including respiratory signs such as cough and nasal discharge, neural signs such as depression, 32 and high mortality rates with most experimentally infected ferrets succumbing within 1 week. 31 While the virus is detected in pharyngeal and rectal secretions, it is currently unclear if ferrets could serve as a transmission model for the disease. 31, 32 Ferrets infected intranasally with henipaviruses similarly display clinical illness. 31, 34 Assessment of immune gene expression by Leon et al 31 in both lungs and brain tissues of the infected ferrets revealed upregulation of macrophage markers such as CD40 and CD80 in both lung and brain tissues, whereas lymphocytic markers were unchanged in the lungs. In terms of humoral responses, increased serum titres of fusion (F) glycoprotein antibodies were seen by 15 d.p.i 20 that were protective against re-infection.
| Respiratory syncytial virus and metapneumovirus
| Ebola virus
Ebola virus disease (EVD) is caused by a zoonotic virus from the Filoviridae family of viruses. 28 This disease can transmit from human to human and causes acute and often fatal disease. Ferrets are able to be directly infected with the Zaire, Bundibugyo and Sudan Ebola strains, 22, 23 which have previously caused major human outbreaks.
Ferrets display hallmarks of pathological processes of human lethal infections such as petechial rashes, reticulated pallor of the liver and splenomegaly. 23, 24 Transmission has also been reported in ferrets. 141 As for immunological studies, transcriptomic sequencing in ferrets 
| K E Y K NOWLEDG E G APS TO ADDRE SS IN ORDER TO IMPROVE THE IMMUNOLOG I C AL UTILIT Y OF FERRE T MODEL S
While the ferret model has unique potential for informative studies into pathogenic viral infections as noted above, addressing several key knowledge gaps will substantially advance the ferret as an immunological model.
| Immunogenetics
There is a lack of well-annotated, ferret genomic sequence infor- Genomic sequencing and assembly of closely related species such as minks 143 are also far from complete, though several similarities such as genome size and relative abundance of repeat elements have been found. In comparison, high-quality draft genome assemblies for dogs and cats are available and have been used for genome-wide association studies 144 and identification of single nucleotide polymorphisms (SNPs). 145 The identification of SNPs in immunoglobulin genes is useful for distinguishing between somatically mutated B-cell receptor sequences and germline variants in affinity-matured antigen-specific B-cell populations. There are currently databases of immunoglobulin sequences for well-established animal models such as those found in the international ImMunoGeneTics (IMGT) information system database 146 and have been useful for identifying somatic hypermutations in immunoglobulin sequences. 147 A curated and annotated database of immune gene sequences is a prerequisite for PCR primer design and post-sequencing data analysis used to recover and express antibodies from single-sorted B cells 148 and recombinant T-cell receptors. 149
| Future T cell-specific reagents for ferrets
Future development of markers to delineate more T-cell subsets will increase the utility of the ferret as an immunological model; a recent report listed several important ferret T cell-specific antibodies to be in production at the CEIRS such as CD4, CCR7, CD3e, CD40, CD40L, CD44, CD62L, CD69, CD103, PD-1, CXCR3, CXCR5, IL-7R
and IL-15R. 109
| Future B cell-specific reagents for ferrets
To increase our understanding of antibody responses in ferrets, flow cytometric reagents that are able to delineate B-cell subsets are required. Important ferret B cell-specific antibodies that are in production at the CEIRS include CD83, CD86, CD95, CD19, CD20, CD25, CD27, CD38, CD138 and FcR. 109
| Current and future markers for ferret myeloid lineage cells
Several markers defining innate cell populations in mice and humans such as CD11b 103,108 and CD14 102 have also been reported to cross-react with ferret leucocytes and have been utilised to characterise ferret innate immune responses. However, these markers have also been found to be expressed in non-myeloid lineages in humans, 150, 151 and other markers such as CD16 152 and CD66 153 will be required to better define myeloid cell populations.
| Ferret immunoglobulin subclass and Fc receptors
Ferret immunoglobulin subclass and Fc receptors are not well studied. Currently, only one IgG subclass that has been identified in ferrets, while four different IgG subclasses have been identified in other carnivores such as dogs 154 and minks 155 such as CD8+ T cells. 163 While a ferret-specific T-cell IFN-γ expression assays 164 to measure CD8 T-lymphocyte activation have been developed and validated, the future elucidation of corresponding antibody/Fc receptor ferret orthologues will enable ferrets to be used to evaluate ADCC responses.
| Antigenic recognition of major influenza proteins
Epitope mapping studies using either human or murine monoclonal antibodies have greatly increased our understanding of influenza viral evolution and allowed the identification of major HA epitopes and pathways of immune escape. While factors that determine the dominant escape mutants are still unknown, such studies have the potential to improve the process of influenza vaccine design. The inability to isolate monoclonal antibodies from ferret B cells has limited studies into the antigenic recognition of influenza proteins in ferrets. Confirming epitope-specific recognition of HA at the monoclonal antibody level in ferrets is critical, as there have been several reports that human and ferret serum antibodies can display variable antigenic recognition. 165, 166 This is critically important as antisera from infected ferrets is widely used in HI assays as part of the strain determination process for influenza vaccines. 167, 168 Major antigenic sites of HA have been localised by generating viral escape mutants in the presence of influenza-specific murine 169, 170 or human 171 monoclonal antibodies, which for H1N1 viruses have been termed Sa, Sb, Ca1, Ca2 and Cb. 170 A study of influenza A (IAV) HA antigenic sites using engineered viruses with mutations in each of the antigenic sites surrounding the RBD revealed species-specific differences in antibody recognition. 166 International Fee Remission Scholarship.
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